Abstract
This issue of Workplace Health & Safety contains a Continuing Nursing Education Module on “Colorectal Cancer Screening: Fecal Occult Blood Test Literature Review for Occupational Health Nurses” 1.0 contact hour of continuing nursing education credit will be awarded by AAOHN upon successful completion of the posttest and evaluation.
A certificate will be awarded when the following requirements are met by the participant: (1) Participant logs on to the AAOHN LMS website at www.aaohn.org/education/online-learning-center and enrolls in the course ($10 members; $15 non-members); (2) The completed posttest and course evaluation are entered online at at http://www.aaohn.org by March 2018; (3) A score of 75% (6 correct answers) is achieved by the participant.
Upon completion of this lesson, the occupational health nurse will be able to:
Discuss CRC and options for colorectal cancer screening in the workplace
The American Association of Occupational Health Nurses, Inc. is an Approved Provider of continuing nursing education by the American Association of Occupational Health Nurses, Inc., an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
The American Association of Occupational Health Nurses, Inc. is additionally approved as a CNE provider by the California Board of Registered Nursing (#CEP9283).
Contact hours received for successful completion of the posttest and evaluation may be used for relicensure, certification, and re-certification.
A case study of a cancer screening in the workplace A trial study evaluating efficacy of colorectal cancer screening methods An integrated literature review that summarizes evidence to support colorectal screening in the workplace A program evaluation report of workplace colorectal cancer screenings at two locations
The fourth most common cause of cancer deaths worldwide Common in developed countries but rarely seen in developing countries A fairly rare form of cancer Common in men but rare in women
Smoking and obesity Ingestion of red meats and processed food Family history of CRC Unknown
PCBs Asbestos Blood and body fluid of farm animals All of the above
Colonoscopy Sigmoidoscopy Fecal occult blood test None of the above
It confirms colon cancer as soon as symptoms appear It can detect blood and other cancer tissue components before the development of clinical symptoms It is available and used worldwide The sedation required is easily tolerated by most individuals
Individuals who use the SDM process understand the risks, benefits, alternatives, and uncertainties of the various CRC screening tests SDM is not conducive to workplace screening programs. SDM has no impact on the likelihood that an individual will complete the FOBT screening test Individuals who do not use SDM are equally likely to be screened for CRC as those who use SDM.
Dietary restrictions are necessary prior to using the gFBOT Anticoagulants should be avoided prior to using gFBOT, but not iFBOT Anticoagulants should be avoided prior to using iFBOT, but not gFBOT Drug restrictions are not recommend for screening programs using either gFBOT or iFBOT